Johnson & Johnson stops mid-stage trial of drug for dengue prevention
Johnson & Johnson has discontinued its mid-stage trial, evaluating an antiviral drug, mosnodenvir, for the prevention of dengue.
Drugs
Health
Pharma
Drugs
Health
Pharma
Recordati buys Sanofi’s drug for autoimmune disease for $825 million
Italy’s Recordati will acquire global rights for Sanofi’s drug Enjaymo, used in the treatment of a rare autoimmune disease that causes the body's.
Drugs
Health
Pharma
EMA starts review of medicines to treat hair loss, prostate enlargement
The European Medicines Agency is reviewing two medicines meant to treat hair loss and prostate enlargement following concerns regarding suicidal ideation and behaviours.
Drugs
Health
Pharma
UK scientists receive funding to develop world’s first ovarian cancer vaccine
HQ Team October 4, 2024: Researchers at the University of Oxford have received £600,000 (€719,960) from Cancer Research UK to fund their project.
Drugs
Health
Medical
Geriatric falls a greater economic burden than firearms injuries
HQ Team October 4, 2024: Falls among the elderly population are a leading cause of injury and can lead to immense physical, emotional.
Drugs
Health
Medical
California state confirms two cases of bird flu, US total stands at 16 now
The US state of California has confirmed two human cases of bird flu, bringing the total number of cases in the current year.
Climate
Health
Medical
‘Communities take primacy in any conversation around health’: Interview
In our search for websites and organizations engaged in community health, public policy and similar endeavors, we came across “The Third Eye’. Named.
Drugs
Health
Medical
Harvard develops drug-free nasal spray to block viruses, bacteria
Harvard University researchers have developed a drug-free nasal spray that blocks, and neutralizes viruses and bacteria.
Drugs
Health
Pharma
AstraZeneca’s experimental blood cancer drug gets US priority review
British-Swedish AstraZeneca’s drug for treatment of a form of blood cancer has been granted a Priority Review in the US by the drug.
Drugs
Health
Pharma
Gilead signs six global pacts to make, sell generic HIV preventive drug
Gilead Sciences, Inc. has signed non-exclusive, royalty-free voluntary licensing agreements with six pharmaceutical makers to make and sell its generic lenacapavir drug for the prevention.